Evidence map›Paper›PMID 19321739›Full record

ArticleAmerican journal of physiology. Cell physiology2009

The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis.

Mary Ann Arndt, Valentina Battaglia, Eva Parisi, Mark J Lortie, Masato Isome, Christopher Baskerville, Donald P Pizzo, Riccardo Ientile, Sebastiano Colombatto, Antonio Toninello and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 73 citations in OpenAlex.

  1. Agmatine induces mitophagy via the PTS-I2R pathway to increase autophagic flux and attenuate sepsis-induced intestinal epithelial cell apoptosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice.International journal of molecular sciences · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genetics of new-onset diabetes after transplantation.Journal of the American Society of Nephrology : JASN · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mary Ann ArndtDivision of Nephrology-Hypertension, University of California-San Diego, San Diego, CA 92161, USA.
Valentina Battaglia
Eva Parisi
Mark J Lortie
Masato Isome
Christopher Baskerville
Donald P Pizzo
Riccardo Ientile
Sebastiano Colombatto
Antonio Toninello
Joseph Satriano
University of San Diego · US

Funding

GLOMERULAR AND TUBULAR FUNCTION IN THE DIABETIC KIDNEYR01DK056248 · NIDDK · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI THOMSON, SCOTT CULVER · 1999 to 2014
$4.6M
AUTOREGULATION OF GLOMERULAR FILTRATION RATER01DK028602 · NIDDK · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI BLANTZ, ROLAND C · 1986 to 2011
$3.9M
Agmatine Mediated Arrest of ProliferationK01DK002920 · NIDDK · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SATRIANO, JOSEPH · 2001 to 2003
$307k
Tool to Define the Antiproliferative Effects of AgmatineR21DK070123 · NIDDK · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI SATRIANO, JOSEPH · 2005 to 2006
$285k
Modulation of Diabetic Kidney Growth/HypertrophyR21DK070667 · NIDDK · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI SATRIANO, JOSEPH · 2006 to 2007
$273k
NIDDK NIH HHS DK-02920NIDDK NIH HHS DK-070123NIDDK NIH HHS DK-070667NIDDK NIH HHS DK-28602NIDDK NIH HHS DK-56248NIDDK NIH HHS R01 DK028602
6 · The paper itself

Abstract

Agmatine, an endogenous metabolite of arginine, selectively suppresses growth in cells with high proliferative kinetics, such as transformed cells, through depletion of intracellular polyamine levels. In the present study, we depleted intracellular polyamine content with agmatine to determine if attrition by cell death contributes to the growth-suppressive effects. We did not observe an increase in necrosis, DNA fragmentation, or chromatin condensation in Ha-Ras-transformed NIH-3T3 cells administered agmatine. In response to Ca(2+)-induced oxidative stress in kidney mitochondrial preparations, agmatine demonstrated attributes of a free radical scavenger by protecting against the oxidation of sulfhydryl groups and decreasing hydrogen peroxide content. The functional outcome was a protective effect against Ca(2+)-induced mitochondrial swelling and mitochondrial membrane potential collapse. We also observed decreased expression of proapoptotic Bcl-2 family members and of execution caspase-3, implying antiapoptotic potential. Indeed, we found that apoptosis induced by camptothecin or 5-fluorourocil was attenuated in cells administered agmatine. Agmatine may offer an alternative to the ornithine decarboxylase inhibitor difluoromethyl ornithine for depletion of intracellular polyamine content while avoiding the complications of increasing polyamine import and reducing the intracellular free radical scavenger capacity of polyamines. Depletion of intracellular polyamine content with agmatine suppressed cell growth, yet its antioxidant capacity afforded protection from mitochondrial insult and resistance to cellular apoptosis. These results could explain the beneficial outcomes observed with agmatine in models of injury and disease.

Indexed as

ApoptosisAgmatineAnimalsAntioxidantsArginineCalciumCamptothecinCaspase 3Cell ProliferationCytoprotectionDNA FragmentationFluorouracilKidneyMembrane Potential, MitochondrialMiceMitochondriaAgmatineAntioxidantsArginineCalciumCamptothecinCasp3 protein, mouseCaspase 3FluorouracilMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePolyaminesProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19321739
PMCPMC2692420
OpenAlexW2123642960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.